During the past decade, Jefferson Headache Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 14 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jefferson Headache Center" #1 sponsor was "Thomas Jefferson University" with 19 trials, followed by "AEON Biopharma, Inc." with 2 trials sponsored, "Satsuma Pharmaceuticals, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Autonomic Technologies, Inc." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson Headache Center" #1 collaborator was "PPD" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Jefferson Headache Center" are "Migraine" (19 trials), "Cluster Headache" (5 trials), "Migraine Headache" (3 trials), "Migraine With Aura" (3 trials) and "Episodic Migraine" (2 trials). Many other conditions were trialed in "Jefferson Headache Center" in a lesser frequency.

Most popular intervention types in "Jefferson Headache Center" are "Drug" (27 trials), "Device" (6 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ABP-450" (2 trials), "Dihydroergotamine" (2 trials), "Sumatriptan" (2 trials) and "0.5% bupivicaine and 2% lidocaine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jefferson Headache Center" are 37 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Jefferson Headache Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Jefferson Headache Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Jefferson Headache Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".